Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1

Melissa J. Cudmore, Shakil Ahmad, Samir Sissaoui, Wenda Ramma, Bin Ma, Takeshi Fujisawa, Bahjat Al-Ani, Keqing Wang, Meng Cai, Fatima Crispi, Peter W. Hewett, Eduard Gratacós, Stuart Egginton, Asif Ahmed

Research output: Contribution to journalArticle

Abstract

Aims - Endothelial dysfunction is a hallmark of preeclampsia. Desensitization of the phosphoinositide 3-kinase (PI3K)/Akt pathway underlies endothelial dysfunction and haeme oxygenase-1 (HO-1) is decreased in preeclampsia. To identify therapeutic targets, we sought to assess whether these two regulators act to suppress soluble endoglin (sEng), an antagonist of transforming growth factor-ß (TGF-ß) signalling, which is known to be elevated in preeclampsia.
Methods and results - Vascular endothelial growth factor-A (VEGF-A), fibroblast growth factor (FGF-2), angiopoietin-1 (Ang-1), and insulin, which all activate the PI3K/Akt pathway, inhibited the release of sEng from endothelial cells. Inhibition of the PI3K/Akt pathway, by overexpression of phosphatase and tensin homolog (PTEN) or a dominant-negative isoform of Akt (Aktdn) induced sEng release from endothelial cells and prevented the inhibitory effect of VEGF-A. Conversely, overexpression of a constitutively active Akt (Aktmyr) inhibited PTEN and cytokine-induced sEng release. Systemic delivery of Aktmyr to mice significantly reduced circulating sEng, whereas Aktdn promoted sEng release. Phosphorylation of Akt was reduced in preeclamptic placenta and this correlated with the elevated level of circulating sEng. Knock-down of Akt using siRNA prevented HO-1-mediated inhibition of sEng release and reduced HO-1 expression. Furthermore, HO-1 null mice have reduced phosphorylated Akt in their organs and overexpression of Aktmyr failed to suppress the elevated levels of sEng detected in HO-1 null mice, indicating that HO-1 is required for the Akt-mediated inhibition of sEng.
Conclusion - The loss of PI3K/Akt and/or HO-1 activity promotes sEng release and positive manipulation of these pathways offers a strategy to circumvent endothelial dysfunction.
LanguageEnglish
Pages1150-1158
Number of pages9
JournalEuropean Heart Journal
Volume33
Issue number9
Early online date16 Mar 2011
DOIs
Publication statusPublished - May 2012

Fingerprint

Heme Oxygenase-1
Pre-Eclampsia
1-Phosphatidylinositol 4-Kinase
Fibroblast Growth Factor 2
Phosphoric Monoester Hydrolases
Vascular Endothelial Growth Factor A
Endoglin
Endothelial Cells
Angiopoietin-1
Transforming Growth Factors
Placenta
Small Interfering RNA
Protein Isoforms
Phosphorylation
Insulin
Cytokines

Bibliographical note

The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this
must be clearly indicated. For commercial re-use, please contact journals.permissions@oup.com.

Keywords

  • endothelium
  • soluble endoglin
  • HO-1
  • PI3K/Akt
  • preeclampsia

Cite this

Cudmore, Melissa J. ; Ahmad, Shakil ; Sissaoui, Samir ; Ramma, Wenda ; Ma, Bin ; Fujisawa, Takeshi ; Al-Ani, Bahjat ; Wang, Keqing ; Cai, Meng ; Crispi, Fatima ; Hewett, Peter W. ; Gratacós, Eduard ; Egginton, Stuart ; Ahmed, Asif. / Loss of Akt activity increases circulating soluble endoglin release in preeclampsia : identification of inter-dependency between Akt-1 and heme oxygenase-1. In: European Heart Journal. 2012 ; Vol. 33, No. 9. pp. 1150-1158.
@article{4dbbdcb0c44045519482e5b6fa7bf265,
title = "Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1",
abstract = "Aims - Endothelial dysfunction is a hallmark of preeclampsia. Desensitization of the phosphoinositide 3-kinase (PI3K)/Akt pathway underlies endothelial dysfunction and haeme oxygenase-1 (HO-1) is decreased in preeclampsia. To identify therapeutic targets, we sought to assess whether these two regulators act to suppress soluble endoglin (sEng), an antagonist of transforming growth factor-{\ss} (TGF-{\ss}) signalling, which is known to be elevated in preeclampsia. Methods and results - Vascular endothelial growth factor-A (VEGF-A), fibroblast growth factor (FGF-2), angiopoietin-1 (Ang-1), and insulin, which all activate the PI3K/Akt pathway, inhibited the release of sEng from endothelial cells. Inhibition of the PI3K/Akt pathway, by overexpression of phosphatase and tensin homolog (PTEN) or a dominant-negative isoform of Akt (Aktdn) induced sEng release from endothelial cells and prevented the inhibitory effect of VEGF-A. Conversely, overexpression of a constitutively active Akt (Aktmyr) inhibited PTEN and cytokine-induced sEng release. Systemic delivery of Aktmyr to mice significantly reduced circulating sEng, whereas Aktdn promoted sEng release. Phosphorylation of Akt was reduced in preeclamptic placenta and this correlated with the elevated level of circulating sEng. Knock-down of Akt using siRNA prevented HO-1-mediated inhibition of sEng release and reduced HO-1 expression. Furthermore, HO-1 null mice have reduced phosphorylated Akt in their organs and overexpression of Aktmyr failed to suppress the elevated levels of sEng detected in HO-1 null mice, indicating that HO-1 is required for the Akt-mediated inhibition of sEng. Conclusion - The loss of PI3K/Akt and/or HO-1 activity promotes sEng release and positive manipulation of these pathways offers a strategy to circumvent endothelial dysfunction.",
keywords = "endothelium, soluble endoglin, HO-1, PI3K/Akt, preeclampsia",
author = "Cudmore, {Melissa J.} and Shakil Ahmad and Samir Sissaoui and Wenda Ramma and Bin Ma and Takeshi Fujisawa and Bahjat Al-Ani and Keqing Wang and Meng Cai and Fatima Crispi and Hewett, {Peter W.} and Eduard Gratac{\'o}s and Stuart Egginton and Asif Ahmed",
note = "The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oup.com.",
year = "2012",
month = "5",
doi = "10.1093/eurheartj/ehr065",
language = "English",
volume = "33",
pages = "1150--1158",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "9",

}

Cudmore, MJ, Ahmad, S, Sissaoui, S, Ramma, W, Ma, B, Fujisawa, T, Al-Ani, B, Wang, K, Cai, M, Crispi, F, Hewett, PW, Gratacós, E, Egginton, S & Ahmed, A 2012, 'Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1' European Heart Journal, vol. 33, no. 9, pp. 1150-1158. https://doi.org/10.1093/eurheartj/ehr065

Loss of Akt activity increases circulating soluble endoglin release in preeclampsia : identification of inter-dependency between Akt-1 and heme oxygenase-1. / Cudmore, Melissa J.; Ahmad, Shakil; Sissaoui, Samir; Ramma, Wenda; Ma, Bin; Fujisawa, Takeshi; Al-Ani, Bahjat; Wang, Keqing; Cai, Meng; Crispi, Fatima; Hewett, Peter W.; Gratacós, Eduard; Egginton, Stuart; Ahmed, Asif.

In: European Heart Journal, Vol. 33, No. 9, 05.2012, p. 1150-1158.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Loss of Akt activity increases circulating soluble endoglin release in preeclampsia

T2 - European Heart Journal

AU - Cudmore, Melissa J.

AU - Ahmad, Shakil

AU - Sissaoui, Samir

AU - Ramma, Wenda

AU - Ma, Bin

AU - Fujisawa, Takeshi

AU - Al-Ani, Bahjat

AU - Wang, Keqing

AU - Cai, Meng

AU - Crispi, Fatima

AU - Hewett, Peter W.

AU - Gratacós, Eduard

AU - Egginton, Stuart

AU - Ahmed, Asif

N1 - The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oup.com.

PY - 2012/5

Y1 - 2012/5

N2 - Aims - Endothelial dysfunction is a hallmark of preeclampsia. Desensitization of the phosphoinositide 3-kinase (PI3K)/Akt pathway underlies endothelial dysfunction and haeme oxygenase-1 (HO-1) is decreased in preeclampsia. To identify therapeutic targets, we sought to assess whether these two regulators act to suppress soluble endoglin (sEng), an antagonist of transforming growth factor-ß (TGF-ß) signalling, which is known to be elevated in preeclampsia. Methods and results - Vascular endothelial growth factor-A (VEGF-A), fibroblast growth factor (FGF-2), angiopoietin-1 (Ang-1), and insulin, which all activate the PI3K/Akt pathway, inhibited the release of sEng from endothelial cells. Inhibition of the PI3K/Akt pathway, by overexpression of phosphatase and tensin homolog (PTEN) or a dominant-negative isoform of Akt (Aktdn) induced sEng release from endothelial cells and prevented the inhibitory effect of VEGF-A. Conversely, overexpression of a constitutively active Akt (Aktmyr) inhibited PTEN and cytokine-induced sEng release. Systemic delivery of Aktmyr to mice significantly reduced circulating sEng, whereas Aktdn promoted sEng release. Phosphorylation of Akt was reduced in preeclamptic placenta and this correlated with the elevated level of circulating sEng. Knock-down of Akt using siRNA prevented HO-1-mediated inhibition of sEng release and reduced HO-1 expression. Furthermore, HO-1 null mice have reduced phosphorylated Akt in their organs and overexpression of Aktmyr failed to suppress the elevated levels of sEng detected in HO-1 null mice, indicating that HO-1 is required for the Akt-mediated inhibition of sEng. Conclusion - The loss of PI3K/Akt and/or HO-1 activity promotes sEng release and positive manipulation of these pathways offers a strategy to circumvent endothelial dysfunction.

AB - Aims - Endothelial dysfunction is a hallmark of preeclampsia. Desensitization of the phosphoinositide 3-kinase (PI3K)/Akt pathway underlies endothelial dysfunction and haeme oxygenase-1 (HO-1) is decreased in preeclampsia. To identify therapeutic targets, we sought to assess whether these two regulators act to suppress soluble endoglin (sEng), an antagonist of transforming growth factor-ß (TGF-ß) signalling, which is known to be elevated in preeclampsia. Methods and results - Vascular endothelial growth factor-A (VEGF-A), fibroblast growth factor (FGF-2), angiopoietin-1 (Ang-1), and insulin, which all activate the PI3K/Akt pathway, inhibited the release of sEng from endothelial cells. Inhibition of the PI3K/Akt pathway, by overexpression of phosphatase and tensin homolog (PTEN) or a dominant-negative isoform of Akt (Aktdn) induced sEng release from endothelial cells and prevented the inhibitory effect of VEGF-A. Conversely, overexpression of a constitutively active Akt (Aktmyr) inhibited PTEN and cytokine-induced sEng release. Systemic delivery of Aktmyr to mice significantly reduced circulating sEng, whereas Aktdn promoted sEng release. Phosphorylation of Akt was reduced in preeclamptic placenta and this correlated with the elevated level of circulating sEng. Knock-down of Akt using siRNA prevented HO-1-mediated inhibition of sEng release and reduced HO-1 expression. Furthermore, HO-1 null mice have reduced phosphorylated Akt in their organs and overexpression of Aktmyr failed to suppress the elevated levels of sEng detected in HO-1 null mice, indicating that HO-1 is required for the Akt-mediated inhibition of sEng. Conclusion - The loss of PI3K/Akt and/or HO-1 activity promotes sEng release and positive manipulation of these pathways offers a strategy to circumvent endothelial dysfunction.

KW - endothelium

KW - soluble endoglin

KW - HO-1

KW - PI3K/Akt

KW - preeclampsia

UR - http://www.scopus.com/inward/record.url?scp=81855193460&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehr065

DO - 10.1093/eurheartj/ehr065

M3 - Article

VL - 33

SP - 1150

EP - 1158

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 9

ER -